On Wednesday, shares in Camp Hill, Pennsylvania headquartered Rite Aid Corp. recorded a trading volume of 23.89 million shares, which was above their three months average volume of 17.53 million shares. The stock ended the day at $8.47, declining 1.63% from the last trading session. The Company's shares have advanced 9.43% in the last one month, 4.31% in the previous three months, and 8.04% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 13.65% and 10.85%, respectively. Furthermore, shares of Rite Aid, which through its subsidiaries, operates a chain of retail drugstores in the US, have a Relative Strength Index (RSI) of 63.15.
On December 20th, 2016, Walgreens Boots Alliance and Rite Aid announced that they have entered into an agreement to sell 865 Rite Aid stores and certain assets related to store operations to Fred's, Inc. for $950 million in an all-cash transaction. Sign up and read the free research report on RAD at:
Walgreens Boots Alliance
Deerfield, Illinois-based Walgreens Boots Alliance Inc.'s stock saw a slight drop of 0.50%, finishing yesterday's session at $85.85 with a total trading volume of 2.17 million shares. The Company's shares have gained 1.69% in the last month, 4.69% over the previous three months, and 2.68% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 3.92% and 5.98%, respectively. Additionally, shares of Walgreens Boots Alliance, which operates as a pharmacy-led health and wellbeing company, have an RSI of 54.86.
On December 21st, 2016, Walgreens announced that it has now expanded availability of naloxone, a lifesaving opioid antidote, without requiring a prescription to Mississippi, Missouri and Washington D.C. That brings the total to 33 states and the District of Columbia where Walgreens makes naloxone available without a prescription. The medication can be dispensed in accordance with each state's pharmacy regulations at nearly 5,800 Walgreens pharmacies. The complimentary research report on WBA can be downloaded at:
Shares in Pittsburgh, Pennsylvania headquartered GNC Holdings Inc. ended Wednesday's session 0.70% higher at $13.00 with a total trading volume of 1.49 million shares. The stock is trading 15.46% below its 50-day moving average. Shares of the Company, which together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products, have an RSI of 29.37.
On December 13th, 2016, research firm Barclays downgraded the Company's stock rating from 'Equal Weight' to 'Underweight' while revising its previous target price from $15 to $11.
On December 20th, 2016, GNC Holdings announced that, for the first time in its history, it will advertise in the Super Bowl, scheduled for February 05th, 2017. The commercial, along with associated placements and promotions, will coincide with the upcoming relaunch of the brand as One New GNC. The company will close all US corporate stores on December 28th, 2016 and reopen December 29th, 2016, as One New GNC. Register for free on Stock-Callers.com and access the latest report on GNC at:
At the close, Dublin, Ohio headquartered Cardinal Health Inc.'s stock dropped 1.00%, finishing at $72.62. A total volume of 3.21 million shares was traded, which was above their three months average volume of 3.08 million shares. The Company's shares have gained 3.37% in the last month. The stock is trading 1.14% above its 50-day moving average. Additionally, shares of Cardinal Health, which operates as a healthcare services and products company worldwide, have an RSI of 49.62.
On November 23rd, 2016, Navidea Biopharma announced that Cardinal Health will purchase Navidea's Lymphoseek® product for lymphatic mapping, lymph node biopsy and the diagnosis of metastatic spread to lymph nodes for the staging of cancer in North America. Navidea will receive $80 million at closing, plus the opportunity to earn up to $230 million of contingent consideration based on certain milestones through 2026.
Yesterday, research firm Leerink Partners downgraded the Company's stock rating from 'Outperform' to 'Market Perform'. Get free access to your research report on CAH at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA